Congresses

Title Yearsort ascending
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening 2019
A novel methodology to identify synergistic drug combinations against non-tuberculous mycobacteria in cystic fibrosis 2019
Towards efficient in vitro screening tools to discover new clinical options in the treatment of non-tuberculous Mycobacteria 2019
PRELIMINARY STUDIES FOR THE ELUCIDATION OF THE MODE OF ACTION OF THE AVERMECTINS AS ANTI-TB AGENTS 2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria 2019
In vitro profiling of anthelmintic avermectins against non-tuberculous mycobacteria 2019
Sanfetrinem, repurposing an oral beta-lactam with intracellular activity for the treatment of tuberculosis 2019
Nuevos métodos para la búsqueda de combinaciones sinérgicas 2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria 2019
New methodologies to test antibiotic susceptibility against emerging pathogens in cystic fibrosis 2019
Mathematical model of meropenem against Mycobacterium tuberculosis 2019
ESTUDIOS DE ELUCIDACIÓN DEL MODO DE ACCIÓN DE LAS AVERMECTINAS FRENTE A MYCOBACTERIUM 2019
Mode of action elucidation studies of the avermectins against Mycobacteria 2019
DEVELOPMENT OF A HIGH-THROUGHPUT METHOD FOR SYNERGISTIC DRUG COMBINATIONS SCREENING 2019
Beta-lactams for Tuberculosis Treatment 2019
Mode of action elucidation studies of a new chemical series active against Mycobacteria and other microbial pathogens 2019
TOWARDS THE ELUCIDATION OF THE MODE OF ACTION OF A NEW CHEMICAL SERIES WITH ANTIMICROBIAL ACTIVITY 2019
Caracterización biológica de una nueva serie de compuestos químicos con actividad antimicrobiana 2018
Sesión II: Antimicrobianos (Moderador) 2018
Estudios iniciales para la caracterización del modo de acción molecular de las avermectinas como agentes anti-tuberculosos 2018

Pages